Cardiopulmonary comorbidity: adipose tissue dysfunction and inflammation as a common pathological hub

Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) often coexist, and their combination markedly increases the risk of adverse outcomes. Epicardial adipose tissue (EAT) and airway-associated/peribronchial adipose tissue (AAT/PBAT) are metabolically active periorgan depots, yet their dysfunction has been studied largely in isolation. Under shared risk factors (smoking, obesity, hypoxia, and physical inactivity), both depots undergo a profound immunometabolic switch from protective metabolic neighbors to pathogenic secretory organs that promote local inflammation and structural remodeling. This review synthesizes current evidence to propose a novel conceptual framework: the adipose-inflammatory interaction network, a unifying pathological hub for cardiopulmonary comorbidity. At the core of this network lies a shared axis of chronic inflammation and metabolic dysregulation, in which each process can amplify the other. Built upon this foundation, paracrine signals from EAT remodel the myocardium and coronary arteries, whereas an analogous paracrine role for AAT/PBAT in the airways is proposed but, in the absence of human COPD data, remains unproven. Superimposed on these layers, circulating adipokines, extracellular vesicle-derived miRNAs, and neuro-immune and neuro-humoral circuits amplify local dysfunction into a systemic, cross-organ state. By mapping this multilevel system, we identify key nodes where metabolic and inflammatory signals converge and position the two depots as sensors and amplifiers of a shared cardiopulmonary inflammatory burden; direct signaling between EAT and AAT/PBAT has not been demonstrated. Epidemiologically, COPD exacerbations drive acute cardiovascular events through acute thromboinflammation acting on a chronic adipose–inflammatory substrate, whereas reverse causation remains unproven. We conclude that this framework clarifies how shared risk factors translate into concomitant cardiopulmonary damage and highlights directions for future research.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-17
DOI
https://doi.org/10.3389/fcvm.2026.2004872
Primary Topic
Cardiovascular Disease and Adiposity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiopulmonary comorbidity: adipose tissue dysfunction and inflammation as a common pathological hub

Li Quanni, Shan Tong, Chanyi He, Jianan Zhang et al.
1 links
Frontiers in Cardiovascular Medicine
Cardiovascular Disease and Adiposity
article

Cardiopulmonary comorbidity: adipose tissue dysfunction and inflammation as a common pathological hub

Li Quanni, Shan Tong, Chanyi He, Jianan Zhang, Tian Xie, Xiaoyu Hou, Shaoyan Zheng, Qi Lin, Wenzhuo Dong
article en

Abstract

Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) often coexist, and their combination markedly increases the risk of adverse outcomes. Epicardial adipose tissue (EAT) and airway-associated/peribronchial adipose tissue (AAT/PBAT) are metabolically active periorgan depots, yet their dysfunction has been studied largely in isolation. Under shared risk factors (smoking, obesity, hypoxia, and physical inactivity), both depots undergo a profound immunometabolic switch from protective metabolic neighbors to pathogenic secretory organs that promote local inflammation and structural remodeling. This review synthesizes current evidence to propose a novel conceptual framework: the adipose-inflammatory interaction network, a unifying pathological hub for cardiopulmonary comorbidity. At the core of this network lies a shared axis of chronic inflammation and metabolic dysregulation, in which each process can amplify the other. Built upon this foundation, paracrine signals from EAT remodel the myocardium and coronary arteries, whereas an analogous paracrine role for AAT/PBAT in the airways is proposed but, in the absence of human COPD data, remains unproven. Superimposed on these layers, circulating adipokines, extracellular vesicle-derived miRNAs, and neuro-immune and neuro-humoral circuits amplify local dysfunction into a systemic, cross-organ state. By mapping this multilevel system, we identify key nodes where metabolic and inflammatory signals converge and position the two depots as sensors and amplifiers of a shared cardiopulmonary inflammatory burden; direct signaling between EAT and AAT/PBAT has not been demonstrated. Epidemiologically, COPD exacerbations drive acute cardiovascular events through acute thromboinflammation acting on a chronic adipose–inflammatory substrate, whereas reverse causation remains unproven. We conclude that this framework clarifies how shared risk factors translate into concomitant cardiopulmonary damage and highlights directions for future research.

Frontiers in Cardiovascular MedicineVol. 13
Hainan General Hospital (CN), Hainan Medical University (CN)
Good health and well-being
Cardiovascular Disease and Adiposity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon